Table 2.

Clinical characteristics of the study population

Variables	Controls, n = 320	IS patients, n = 316	P value
Age, years (Mean ± SD)	60.72 ± 10.77	62.23 ± 11.36	0.087
Gender (M / F)	204 / 116	216 / 100	0.220
Hypertension (%)	59 (18.4%)	126 (39.9)	< 0.001
Diabetes mellitus (%)	30 (9.4%)	50 (15.8%)	< 0.001
Smoker (%)	50 (15.6%)	98 (31.0%)	< 0.001
TCH (mmol/L)	4.19 ± 0.79	4.64 ± 1.16	< 0.001
TG (mmol/L)	1.37 ± 0.99	1.81 ± 1.31	< 0.001
HDL-C (mmol/L)	1.50 ± 0.31	1.13 ± 0.32	< 0.001
LDL -C (mmol/L)	2.39 ± 0.66	2.92 ± 0.98	< 0.001
Apo-A1(g/L)	1.73 ± 1.10	1.23 ± 0.26	< 0.001
Apo-B (g/L)	0.77 ± 0.31	1.00 ± 0.31	< 0.001
NEFA (mmol/L)	0.71 ± 0.30	0.53 ± 0.28	< 0.001

IS ischemic stroke, SD Standard deviation, M Male, F Female, TC Total cholesterol, TG Triglyceride, HDL-C High density lipoprotein-cholesterol, LDL-C Low density lipoprotein-cholesterol, Apo-A1 Apolipoprotein A1, Apo-B Apolipoprotein B, NEFA Non-esterified fatty acid